Tennessee Oncology Partners with Clinicast for Patient Risk Analytics

Clinicast, a leading provider of risk stratification and analytics, to support one of the largest independent oncology practices in the country.

For Immediate Release…December 5, 2014…Millbrae, California —Clinicast, a leading provider in patient risk stratification and analytics to support data-driven oncology, announces Tennessee Oncology will implement the Clinicast ARTO™ Oncology platform.

Cancer care is increasingly becoming a data problem:  how can oncology providers’ aggregate diverse data sources in order to match the right patient with the right intervention at the right time, consistent with best scientific evidence and resource constraints?

Clinicast’s cloud-based ARTO™ Oncology platform will enable Tennessee Oncology to identify high-risk oncology patients, better match patients to appropriate interventions, measure intervention effectiveness and benchmark performance through powerful, predictive models.  Alignment with Clinicast will enhance the success of Tennessee Oncology’s medical home and accountable care organization initiatives with several commercial health plans in the Tennessee market.

“We examined a number of systems that operate on payer-based data, and found our payer partners already have patient risk stratification models they are generally willing to share – but these models lack the robustness that can be garnered from inclusion of a practice’s EMR data,” said Wes Chapman, senior vice president of Tennessee Oncology. “Clinicast gives us an oncology-specific analytics system that includes our patients’ clinical data. This will allow us to improve data-driven healthcare decisions that are tailored to risk assessments of each individual patient”.

“Tennessee Oncology has a long-standing reputation for innovation and thought leadership in oncology, which translates to state-of-the-art cancer care for its patients,” said Jack Challis, CEO of Clinicast. “We’re excited about the opportunity to work with Tennessee Oncology. We look forward to a strong and collaborative partnership as we work together to improve the quality and efficiency of oncology care.”

About Tennessee Oncology

Tennessee Oncology, PLLC is one of the nation’s leading teams of cancer care specialists, nationally recognized for improving patient outcomes through clinical trial research and innovative treatments. Its comprehensive range of cancer care services include specialized oncology nursing care, laboratory services, outpatient chemotherapy, PET/CT services and patient education and support services. Founded in 1976, Tennessee Oncology is one of the largest physician-owned practices in the country with nearly 80 physician partners in 30 locations throughout Middle and Southeast Tennessee. Visit tnoncology.com for more information.

About Clinicast

Clinicast’s mission is to build the language of data-driven healthcare, by empowering healthcare stakeholders to make informed decisions that maximize outcomes and minimize costs.  Clinicast’s ARTO™ Oncology platform provides a comprehensive oncology solution that enables providers to reduce cost variation in managing cancer care without compromising on patient outcome or quality.  The company emerged from the highly-rated Californian health sector incubator, Rock Health in 2012 and is based in Millbrae, California. Visit www.clinicast.net for more information.



Jack Challis, CEO





IOM Report : America Needs Affordable, Value-Driven Cancer Delivery System

America’s cancer care system is in crisis, as outlined by the Institute of Medicine’s recent 315-page report. With the aging of America’s baby boomers, the annual cost of cancer management is expected to grow from $145 B today to $225 B in 2020. Without a change in direction, the system will simply not be able to provide quality care to everyone who needs it.

A key component of the IOM report is to incorporate more learning systems into clinical practice and research. Quoting from the summary report:

“A learning health care IT system would enable real-time analysis of data from cancer patients in a variety of care settings to improve knowledge and inform medical decisions. This IT system would collect and analyze data from clinical practice, implement changes to improve care, evaluate the outcomes of these changes, and generate new hypotheses to test and implement.”

At CliniCast, we couldn’t agree more. Data is an underutilized resource in promoting better clinical practice, adapting patient care pathways to account for each patient’s needs and wishes, and identify costly variances in care. No one is served when a patient receives high-resource care without improvement in their outcome or quality of life.

If you would like to learn more about tools that identify variances in oncology care, assess underlying causes, and help patients achieve the Triple Aim of better outcomes, improved quality of care and substantially lower cost, I encourage you to e-mail me at jack@clinicast.net or visit our website: http://clinicast.net/ .